|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR MEDICINE |
1 Department of Cardiology B, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
2 Department of Cardiology Y, Bispebjerg University Hospital, Copenhagen, Denmark
3 Department of Cardiology P, Gentofte University Hospital, Copenhagen, Denmark
Correspondence to:
Correspondence to:
Dr Finn Gustafsson
Department of Cardiology B 2012, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; finng{at}dadlnet.dk
Objectives: To evaluate the importance of a history of hypertension on long-term mortality in a large cohort of patients hospitalised with congestive heart failure (CHF).
Design: Retrospective analysis of 5491 consecutive patients, of whom 24% had a history of hypertension. 60% of the patients had non-systolic CHF, and 57% had ischaemic heart disease.
Setting: 38 primary, secondary and tertiary hospitals in Denmark.
Main outcome measures: Total mortality 58 years after inclusion in the registry.
Results: Female sex and preserved left ventricular systolic function was more common among patients with a history of hypertension. 72% of the patients died during follow up. A hypertension history did not affect mortality risk (hazard ratio (HR) 0.99, 95% confidence interval (CI) 0.92 to 1.07). Correction for differences between the normotensive and hypertensive groups at baseline in a multivariate model did not alter this result (HR 1.08, 95% CI 1.00 to 1.17, p = 0.06). The hazard ratio was similar in patients with and without a history of ischaemic heart disease. Hence, a specific effect of hypertension in the group of patients with CHF with ischaemic heart disease, as suggested in earlier studies, could not be confirmed.
Conclusion: A history of arterial hypertension did not affect mortality in patients hospitalised with CHF.
Abbreviations: ACE, angiotensin-converting enzyme; CHF, congestive heart failure; DIAMOND, Danish Investigations of Arrhythmia and Mortality; HR, hazard ratio; LVEF, left ventricular ejection fraction; MERIT-HF, Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure; WMI, wall motion index
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |